Projekt

Swiss Soliris® and Ultomiris® Reimbursement Registry SSURR: An observational registry for capturing data of patients suffering from paroxysmal nocturnal hemoglobinuria (PNH) who are treated with Soliris® (eculizumab) or Ultomiris® (ravulizumab)

Laufend - Rekrutierung – laufend · 2021 bis 2030

Silzle Tobias, Demmer-Steingruber Ruth, Müller Fiona